Dublin-based agritech company Antler Bio has secured €3.6 million in funding to scale its gene expression platform, EpiHerd, across Europe.
The startup, which turns complex biological data into actionable insights for dairy farmers, now brings its total funding to over €7.2 million including grants.
Leading the round
The round was led by The First Thirty Ventures, with participation from Endgame Capital and Generation-RE. These investors focus on agricultural innovations that improve both food production and human health outcomes.
Advertisement
What Antler Bio does
Founded in 2020, Antler Bio developed EpiHerd, a platform that helps farmers understand how their cows’ genes react to environmental and nutritional factors. Already active on over 100 farms in the UK, Finland, Sweden, and Denmark, EpiHerd users have seen milk yield improvements of up to 22% and significant gains in milk quality and herd longevity.
Strategic impact and expansion
Amid rising pressures in the dairy industry—declining farm numbers, regulatory shifts, and shrinking milk production across the US and EU—Antler Bio offers a tech-driven way to maximize herd efficiency without increasing herd size. The new capital will be used to grow the team and scale operations across more farms in Europe.
Why it matters
Antler Bio’s model of merging biology with AI-driven insights exemplifies a broader trend toward precision agriculture. As co-founder and CEO Maria Jensen put it, the funding will help “benefit farmer profits, but importantly, the well-being of their animals.”
